ATP shares initial findings from its COVID-19 Antibody study and COVID-19 survey
Alberta’s Tomorrow Project is celebrating 20 years since it first launched in 2001, and as a part of that, we are pleased to share initial findings from our COVID-19 Antibody (CAT) study and COVID-19 survey. The findings below reflect data collected and analyzed from when the study first began to the four-month follow-up appointment.
We are seeing more than 96 per cent retention rate in this study, and we are thankful for our dedicated participants for helping us better understand the COVID-19 virus and how it influences the health and wellbeing of Albertans.
Findings and trends
- More than 4000 participants joined the CAT study in Calgary, Edmonton, Red Deer and Lethbridge over a one-year period – thank you for your participation!
- We saw 96 per cent of participants return for their 4-month follow-up and 99 per cent of them completed their survey.
- Almost four per cent of CAT participants have had COVID-19.
- More than 90 per cent of study participants are vaccinated.
- 73 per cent of participants indicated they had no concerns about the vaccine; of those that did, the most common concern around getting vaccinated is the unknown future effects of the vaccine.
- Evidence to date supports the safety and efficacy of vaccines. Please read more on the Alberta Health Services website: Facts the only cure for vaccine misinformation | Alberta Health Services.
We know the pandemic has influenced many aspects of our lives. From when we first began the study to the 4-month follow-up:
- 23 per cent reported higher alcohol consumption
- 22 per cent reported greater anxiety
- 14per cent reported a reduction in household income
- 19 per cent experienced an increase in depressive symptoms